Revance Therapeutics Inc (NASDAQ:RVNC)

BATS BZX Real-Time Price
As of 3:05pm ET
 -0.27 / -2.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Revance Therapeutics Inc have a median target of 35.00, with a high estimate of 65.00 and a low estimate of 15.00. The median estimate represents a +188.07% increase from the last price of 12.15.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Revance Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.70%
Growthannually 12.69%


Growthquarterly 6.93%
Growthannually 85.87%
Key to the earnings and sales forecast charts.